A case of unilateral nevoid hyperkeratosis of the nipple and areola.

角化过度 皮肤病科 乳晕 医学 乳头状瘤病 棘皮病 黑棘皮病 角化不良 表皮松解性角化过度 病因学 病理 肥胖 胰岛素抵抗
作者
Jiaolin Ning,R. Zhang,Wenxuan Zhu
出处
期刊:European Journal of Pediatric Dermatology 卷期号:31 (1): 47-49 被引量:1
标识
DOI:10.26326/2281-9649.31.1.2215
摘要

Discussion. In 1923, Tauber first described hyperkeratosis of the nipple and areola, which was characterized by a slowly growing thickening and pigmentation of the nipple and areola (5). In 1938, Levy-Frankel further classified the condition into three types: (i) nevoid form (NHNA) or idiopathic type; (ii) in conjunction with other skin disorders; (iii) extension of an epidermal nevus (2). Considering this classification, our patient has the nevoid form or idiopathic type of hyperkeratosis. This type is usually bilateral, presenting as persistent verrucous thickening and dark pigmentation in the involved areas (6). The lesions are generally asymptomatic but are occasionally itchy. The etiology of NHNA is not known. Realizing that this condition usually occurs in females in their second and third decades of life, it was speculated that the occurrence of NHNA is related to sharp hormonal changes as menarche or pregnancy (3). The diagnosis of NHNA is always by exclusion and needs confirmation by histologic examination. The specific pathological features include hyperkeratosis, acanthosis and papillomatosis and mild perivascular lymphocytic infiltrates, occasionally with keratotic plugging (4). Our patient refused our request for a biopsy and the diagnosis of unilateral NHNA was based on the clinical features. Despite being a benign disease, NHNA is distressing for patients, since the thickened skin shows an esthetically disturbing appearance. For clinicians it is therapeutically challenging, because there is no effective treatment for this condition. Mismanagement may threaten breast function or could lead to a bad esthetic result. Various modalities have been tried, but the results varied widely. Topical application of corticosteroids, tretinoin, keratolytics, calcipotriol and etretinate have been reported. Some Authors described treatment with radiofrequency, surgery and shave excision (1).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
领导范儿的应助被aANDb采纳,获得10
刚刚
1秒前
1秒前
DW的应助被HgPP采纳,获得10
1秒前
大个的应助被找不到文献采纳,获得10
1秒前
1秒前
xyx2999完成签到,获得积分10
2秒前
科目三的应助被tulipqq采纳,获得10
2秒前
2秒前
佳无夜完成签到,获得积分10
2秒前
2秒前
单纯涫完成签到 ,获得积分20
3秒前
ming完成签到 ,获得积分10
3秒前
YY531161945完成签到,获得积分10
3秒前
moonli完成签到,获得积分10
3秒前
3秒前
biyebiye完成签到,获得积分10
4秒前
大方寄风完成签到,获得积分10
4秒前
4秒前
湘月发布了新的文献求助10
4秒前
fffbl发布了新的文献求助10
4秒前
Lucas的应助被学术虫采纳,获得10
4秒前
小朱完成签到 ,获得积分10
5秒前
little完成签到,获得积分10
5秒前
阿苏勒发布了新的文献求助10
5秒前
111完成签到,获得积分20
5秒前
NexusExplorer的应助被JYX采纳,获得10
6秒前
6秒前
梦龙南舟发布了新的文献求助10
7秒前
稳重的无招完成签到,获得积分10
7秒前
7秒前
7秒前
自信半雪完成签到,获得积分10
7秒前
YY531161945发布了新的文献求助10
7秒前
泡泡123123完成签到,获得积分10
7秒前
lucky完成签到,获得积分10
7秒前
Hello的应助被lx采纳,获得10
7秒前
yym关注了科研通微信公众号
8秒前
Guangyue发布了新的文献求助30
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
Narrative Disclosure and Earnings Performance: Evidence from R&D Disclosures 1050
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Positive Psychology 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8006411
求助须知:如何正确求助?哪些是违规求助? 9457036
关于积分的说明 21164569
捐赠科研通 7578982
什么是DOI,文献DOI怎么找? 3382295
关于科研通互助平台的介绍 2515022
邀请新用户注册赠送积分活动 2417206